Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Lifecare AS ( (DE:LFC0) ).
Lifecare ASA has reminded investors that the exercise window for its Warrant Series 1, issued as part of a partially underwritten rights issue completed in January 2026, runs from 2 March to 13 March 2026, allowing each warrant holder to subscribe for one new share at NOK 0.3342. The company warns that unexercised warrants will lapse without value and may dilute non-participating holders, while noting that board chair and primary insider Morten Foros Krohnstad has exercised 1.6 million warrants, with the related share capital increase expected to be registered around 25 March and new shares delivered around 26 March 2026, underscoring insider confidence and near-term capital strengthening.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a primary emphasis on next-generation continuous glucose monitoring systems. Its osmotic pressure-based sensor technology is designed for detecting and tracking a wide range of analytes and molecules in humans and pets, positioning the firm within the advanced medtech and diagnostics market.
Average Trading Volume: 2,808,667
Current Market Cap: NOK77.38M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.